Janus Clinical Trials Repository: Modernizing the Review Process through Innovation

Similar documents
CDASH Clinical Data Acquisition Standards Harmonization

Putting CDISC Standards to Work How Converting to CDISC Standards Early in the Clinical Trial Process Will Make Your CDISC Investment Pay

Exploration des données d essais cliniques en utilisant le standard CDISC

October, Integration and Implementation of CDISC Standards

JMP JMP Pro JMP Genomics JMP Clinical JMP Add-Ins

CDISC Data Standards Validation

CDISC Standards: Current and Future

Innovations in Clinical

CDISC/TransCelerate Collaboration and TransCelerate work streams. -Clinical Data Standards -Common Protocol Template -esource

Industrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence

Welcome to the American College of Toxicology s Webinar Series. We will begin at 11AM EDT

Applying SDTM and ADaM to the Construction of Datamarts in Support of Cross-indication Regulatory Requests

End-to-End Management of Clinical Trials Data

CDISC Controlled Terminology across the Clinical Trial Continuum. Bay Area Implementation Network 6 March 2008

LOINC in Regulated Clinical Research a Lab LOINC Steeringg Committee Meeting 08 June 2017

Evolving Regulatory Guidance on Submission of Standardized Data. James R. Johnson, PhD RTP CDISC User Network

FDA Experience with the Sentinel Common Data Model: Addressing Data Sufficiency

E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research

TOTAL CANCER CARE: CREATING PARTNERSHIPS TO ADDRESS PATIENT NEEDS

PharmaSUG 2017 Paper DS14

Implementation and Operation of CDISC ODM-based EDC by UMIN

Comments from the FDA Working Group on SUBGROUP ANALYSES. Estelle Russek-Cohen, Ph.D. U.S. Food and Drug Administration Center for Biologics

CDISC UK Network face to face Reading

Safety Assessment of Pharmaceutical Products. Christy Chuang-Stein, Pfizer Inc. BASS XIX

Analyzing Data with Power BI

Electronic Health Records and Clinical Data Interchange Standards

CRO partner in Rx/CDx Co-Development

Genomics And Pharmacogenomics In Anticancer Drug Development And Clinical Response (Cancer Drug Discovery And Development)

SYMPOSIUM March 22-23, 2018

Optimizing Your Study Data Submissions to FDA Updates from CDER and CBER

COURSE LISTING. Courses Listed. with Business Intelligence (BI) Crystal Reports. 26 December 2017 (18:02 GMT)

The Enterprise Project

National Food Safety Data Exchange Pilot (NFSDX)

Regulatory Challenges of Global Drug Development in Oncology. Jurij Petrin, M.D. Princeton, NJ

Standard Operating Procedures Guidelines for Good Clinical Practice

Guidance for Industry - Computerized Systems Used in Clinical Trials

PI SERVER 2015 AND FUTURE DATA

EAUTIFUL BDATA AGGREGATION EXTRAVAGANZA. Implementing a Clinical Data Repository and Analytics Platform in 90 Days

Advancing Regulatory Science for Medical Countermeasures Development: An Institute of Medicine Workshop

CDASH 2.0. Berlin Éanna Kiely CDISC Engineer

HD Regulatory Science Consortium (HD-RSC) A consortium aimed at accelerating treatments for Huntington s disease

Dr. Rob Donald - Curriculum Vitae. Web: Mob:

EFPIA-PHRMA PRINCIPLES FOR RESPONSIBLE CLINICAL TRIAL DATA SHARING REPORT ON THE 2016 MEMBER COMPANY SURVEY

FDA > CDRH > CFR Title 21 Database Search

Adverse Event Reporting

JMP Clinical 4.0 adds Ways to Explore Clinical Trials Data Visually

Bridging the Genomics-Health IT Gap for Precision Medicine

From Standards that Cost to Standards that Save: Cost Effective Standards Implementation

Enabling faster insights to improve clinical trial efficiency and quality

THE VISUALIZATION AND ANALYSIS OF IMMUNO-ONCOLOGY STUDIES USING JMP CLINICAL

Genomic Data Is Going Google. Ask Bigger Biological Questions

How to Improve Healthcare Payer Operations with Data

Sonja Brajovic Medical Officer, Office of Surveillance and Epidemiology Center for Drug Evaluation and Research Food and Drug Administration

Data Quality and Integrity: From Clinical Monitoring to Marketing Approval

Clinical Data Acquisition Standards Harmonization (CDASH)

The use of electronic Health Records in Clinical Research - The value of CDISC Standards

Perspective: Convergence of CLIA and FDA Requirements A Rational Shift in the Regulatory Paradigm

Biomarker Data Management in Clinical Trials: Addressing the Challenges of the New Regulatory Landscape

Chapter 1. Pharmaceutical Industry Overview

SINGLE VIEW OF THE TRUTH? DO YOU NEED A

ACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes

REIMAGINING DRUG DEVELOPMENT:

The Alpine Data Platform

PCORI Methodology Standards: Academic Curriculum Patient-Centered Outcomes Research Institute. All Rights Reserved.

Introducing 2-Tier BI and Analytics

PhUSE. PhUSE Computational Science Standard Analyses and Code Sharing Working Group

Collaboration and Content Management with Alfresco Enterprise & JBoss Portal

Analyzing Data with Power BI

Clinical Information Interoperability Council (CIIC) Providing a Shared Repository of Detailed Clinical Models for all of Health and Healthcare

Business Intelligence Intelligent Business

ectd: A Clinical Reviewer s Experience Sarah M. Connelly, MD Medical Officer Division of Antiviral Products FDA

Leveraging adult data in pediatric product development: The role of Bayesian statistics

Industry Academic Collaboration: A Key to Successful Involvement of Patients Early in Clinical Development

Non-clinical Assessment Requirements

Audience Profile The course will likely be attended by SQL Server report creators who are interested in alternative methods of presenting data.

Canadian Cancer Clinical Trials Network Portfolio Eligibility Criteria and Guidelines

ISPE Comments on the CIOMS 2006 draft Special Ethical Considerations for Epidemiologic Research 1

OHM MODULES. Appointment Scheduler. Billing Manager. For more information call or visit ULehssustainability.com/ohm

Reimbursement Strategy for Companion Diagnostics:

The Role of the CRO in Effective Risk-Based Monitoring

Devices, Big Data, and Real World Evidence O R A C L E W H I T E P A P E R O C T O B E R

Symphony Genomics Workflow Management System Managing, Integrating, and Delivering Your NGS Data and Results

Food and Drug Administration (FDA) 101

UNCLASSIFIED. FlexFiles. The Future of Cost Analysis

The Future of Clinical and Pharmaceutical Research

New Frontiers in Personalized Medicine

AACT-Results: The Results dataset extensions for the AACT database

OCTC 2012 CRO Selection

Statistical Review and Data Standards: It s Gettin Better All The Time

8 th Kitasato- Harvard Symposium

Introduction to SureSource

Interoperability for clinical research Observational Health Data Sciences and Informatics (OHDSI)

CFAST Therapeutic Area Program Steering Committee 2013 Meeting Summaries (January-August)

Steps and Slides of Implementing Global Standards Producing High Quality Programming Outputs Edition

Project Data Sphere Data Sharing in Cancer Research. Joel Beetsch, PhD Faster Cures, November 4th, 2013

22 nd February Utilizing big data to enhance patient recruitment

THE MAGIC OF DATA INTEGRATION IN THE ENTERPRISE WITH TIPS AND TRICKS

Standard for Exchange of Nonclinical Data Implementation Guide: Nonclinical Studies

GET MORE VALUE OUT OF BIG DATA

Energy Future Holdings (EFH)

Transcription:

Janus Clinical Trials Repository: Modernizing the Review Process through Innovation Lilliam Rosario, Ph.D. Director Office of Computational Science Food and Drug Administration

Janus Clinical Trials Repository (CTR) Regulatory Review Data Views Analytical Tools Standardized Data CTR Meta-Analysis Data Marts Analytical Tools Other 2

Janus Clinical Trials Repository Supports automated extraction, transformation, loading, management, and reviewer access to standardized clinical trials data to support the regulatory review of therapeutic biologic and drug products Incorporates data marts designed to address specific needs Enables queries to be run using various analytic tools from these data marts to meet individual reviewer needs Leverages pre-specified analysis scripts and analytic tools 3

CTR is Large Data CTR is designed to handle large data-sets o Is expected to grow into a very large data warehouse with many data marts. o Expected to grow by a few TB s every year CTR primarily handles: o Structured data o Low Velocity (~600 applications a year) o Analysis and reporting requirements are in real-time 4

CTR - Big Data Vision CTR will evolve into a big data system in the future Integrate other data-sets o To support the personalized medicine paradigm o Post marketing data o Other Data Explore no-sql and Hadoop in the future 5

Facilitating Modernization of the Regulatory Review Process 6

Intersection of data, tools and technology Standardized Data Data Data Data Data Warehouse Data Validation Data marts Analytic Tools Reviewer Decisions Repositories for Electronic Data Computational Science Center (CSC) Reviewer Services 7

Data Warehouse and Data Marts 8

Improve Data Storage/Access Develop and implement a clinical trials data warehouse that supports the validation, transformation, loading, and integration of study data Support reviewer access to the data via a variety of analytic views (or data marts) and analytic tools 9

Why Do We Need a Clinical Trials Repository (CTR)? Clinical Trials Data will be easily accessible o One-stop shopping o Self-service Data will be more predictable o Consistent in format, content, definitions from study to study, sponsor to sponsor Data will be of higher quality o Data validation service will help insure minimum level of quality data Improved productivity o Less time needed for routine data management tasks o More time to do the analysis & interpret results Support Standard Analyses / Reports Support Cross-study Analyses 10

Janus CTR and the 21 st Century Drug Review Process True potential of standardized data is unleashed with Janus CTR o Study data automatically transformed into views that are more reviewer-friendly Demographic and Treatment Assignment information in every dataset Numeric Dates Full MedDRA Hierarchy for all adverse events o Data curation capabilities to Correct misspellings; problems with coding (submitted data is not altered!) Convert lab units to U.S. conventional units o Enables pooling of data within an application, across a drug class, or even across drug classes o Facilitates timely creation of custom data marts to support a variety of meta-analysis needs Janus CTR will piloted in early 2014 in to support the JumpStart Service (in parallel with tools currently used) o Study Data from applications enrolled in JumpStart will be loaded into CTR 11

Janus Clinical Trials Repository (CTR) CDISC SDTM 3.1.2 CDISC SDTM 3.1.x Enhanced CDISC SDTM Views Regulatory Review SAS JMP R JReview CTR Tools HL7 FHIR CTR Meta-Analysis Other Diabetes Safety Risk Analysis (View/Mart) Bladder Cancer Fractures SAS JMP R JReview CTR Tools Other 12

Janus Clinical Trials Repository Supports automated extraction, transformation, loading, management, and reviewer access to standard clinical trials data to support the regulatory review of therapeutic biologic and drug products Incorporates data marts designed to address specific needs, such as therapeutic areas, SDTM views for tools, etc. Enables queries to be run using various analytic tools from these data marts to meet individual reviewer needs Leverages pre-specified analysis scripts and analytic tools 13

Intersection of data, tools and technology Standardized Data Data Data Data Data Warehouse Data Validation Data marts Analytic Tools Reviewer Decisions Repositories for Electronic Data Computational Science Center (CSC) Reviewer Services 14

JReview Tools MAED (MedDRA Adverse Events Diagnostics) SAS Analysis Panels JMP FDA Investigator s Rapid Review Service (FIRRS) NIMS (Non-clinical Information Management System) Analytic Tools Overview Allows users to tabulate, visualize, and analyze safety and efficacy data Provides a catalogue of standard analyses with drill down capabilities, making it easy to obtain results and graphical displays of common analyses, such as Hy s Law (relies on availability of SDTM study data) Allows dynamic and efficient review of adverse event data Performs over 200 Standardized MedDRA Queries and Adverse Events analyses on all levels of the MedDRA hierarchy in minutes Provides standard analyses (Demographics, Disposition, Exposure, Adverse Events, and Liver Labs) in Excel or Word Combines powerful statistics with dynamic graphics to enable review process Assesses the sponsors data management and coding quality Helps reviewers understand the contents of the data Enables dynamic study visualization, search, orientation, and analytics capabilities in the review of non-clinical data Enables cross-study metadata and study data searching across the data repository (across studies, class, findings, and finding types) Allows reviewers to see all findings for an individual animal in one place 15

CSC JumpStart Service Starts a review by performing many standard analyses and identifying key information 16

CSC JumpStart Service Provides a recommended sequence for using the outputs Allows reviewer to follow a safety signal from a high-level to the specific patient details with complementary tools MAED: System Organ Class Identifies a difference between treatment arms for both risk difference and relative risk. MedDRA at a Glance Report Shows same signal across multiple levels of the hierarchy for the treatment arm. JReview: Risk Assessment Magnifies the safety signal when viewing patients that were not treated with the study drug. JReview: Graphical Patient Profile Shows which patients experienced the Adverse Event shortly after taking a specific concomitant medication. 17

Planned CTR Support of JumpStart Service MAED: System Organ Class Identifies a difference between treatment arms for both risk difference and relative risk. MedDRA at a Glance Report Shows same signal across multiple levels of the hierarchy for the treatment arm. JReview: Risk Assessment Magnifies the safety signal when viewing patients that were not treated with the study drug. JReview: Graphical Patient Profile Shows which patients experienced the Adverse Event shortly after taking a specific concomitant medication. CTR Enhanced CDISC SDTM Views Regulatory Review SAS JMP R JReview CTR Tools Additional Views to Support Regulatory Review 18

CTR Tools to Support JumpStart CTR Standard Analysis Reports (web-based application) o Standardized reports that support safety review, including safety reports supported by JumpStart Study & Standards Browser (web-based application) Ad Hoc Query Tool (web-based application) Data Curation 19

CTR Reports Over 60 standardized reports Includes MAED, FIRRS and standard analysis reports. Users can filter data prior to running each report

Study & Standards Browser Consolidates all study meta-data o Access summary information about the study (Study design, trial summary, explanation of codes used, location of specific variables, etc.) o Study specific transforms, preferences and reports o User defined tags for other meta-data Reviewer Log o Ability to go back in time and recreate analyses 21

Study & Standards Browser 22

Ad-Hoc Query Tool Allows reviewers to manipulate data by o Pooling of data across studies o Filtering o Sub-setting o Complex queries with logical operators Reviewers can create and download customized analysis ready datasets from the CTR o From a single study o Across multiple studies Provides a framework for developing meta-analysis reports 23

Ad-Hoc Query Tool 24

Timeline for Janus Clinical Trials Repository 2012 through 2014 Contractor Support through NCI/SAIC-Frederick CTR Development at NCI 3-Year Project Funded by ARRA CER Transitional O&M and Enhancement Support Enhancement Support (CDER IDIQ) Prototyping & development of study browser, ad hoc query, data curation capabilities Transitional O&M Support (IAA with NCI) 2013 2014 2012 2012 Oct Dec Feb Apr Jun Aug Oct Dec Feb Apr Jun Aug 2014 Today

Future Directions CTR marks the first step to integration of diverse and bigger data o o o CTR is designed to handle large data-sets Is expected to grow into a very large data warehouse with many data marts. Expected to grow by a few TB s every year CTR will evolve into a big data system in the future Integrate other data-sets o To support the personalized medicine paradigm o Pre market and Post marketing data o Other Data (pharmacogenomics, large simple trials, therapeutic area specific databases o Support nonclinical data to clinical correlations 26

Conclusion Rapidly moving towards a modernized, integrated bioinformatics-based review environment High quality, standardized data Easy data analysis using leading practices Access to powerful, standard data-based review tools 27